Nanotechnology-based multifunctional vaccines for cancer immunotherapy
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nanotechnology-based multifunctional vaccines for cancer immunotherapy
Authors
Keywords
Nanovaccine, Cancer immunotherapy, DC vaccines, ICB, Antitumor immune response
Journal
CHEMICAL ENGINEERING JOURNAL
Volume 437, Issue -, Pages 135505
Publisher
Elsevier BV
Online
2022-02-27
DOI
10.1016/j.cej.2022.135505
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antigen epitope-TLR7/8a conjugate as self-assembled carrier-free nanovaccine for personalized immunotherapy
- (2022) Huijuan Song et al. Acta Biomaterialia
- Nanovaccine‐Based Strategies to Overcome Challenges in the Whole Vaccination Cascade for Tumor Immunotherapy
- (2021) Lin Qin et al. Small
- A Versatile and Robust Platform for the Scalable Manufacture of Biomimetic Nanovaccines
- (2021) Hanze Hu et al. Advanced Science
- Personalized Nanovaccine Coated with Calcinetin-Expressed Cancer Cell Membrane Antigen for Cancer Immunotherapy
- (2021) Xiang Xiong et al. NANO LETTERS
- Biomimetic sonodynamic therapy-nanovaccine integration platform potentiates Anti-PD-1 therapy in hypoxic tumors
- (2021) Guiting Zhan et al. Nano Today
- A Redox‐Responsive Nanovaccine Combined with A2A Receptor Antagonist for Cancer Immunotherapy
- (2021) Peng Yan et al. Advanced Healthcare Materials
- Nanovaccines silencing IL-10 production at priming phase for boosting immune responses to melanoma
- (2021) Cao Dai Phung et al. JOURNAL OF CONTROLLED RELEASE
- Engineered Nanovaccine Targeting Clec9a+ Dendritic Cells Remarkably Enhances the Cancer Immunotherapy Effects of STING Agonist
- (2021) Shanshan Gou et al. NANO LETTERS
- Supramolecular co-assembly of self-adjuvanting nanofibrious peptide hydrogel enhances cancer vaccination by activating MyD88-dependent NF-κB signaling pathway without inflammation
- (2021) Qi Su et al. Bioactive Materials
- Sequential and timely combination of cancer nanovaccine with immune checkpoint blockade effectively inhibits tumor growth and relapse
- (2020) Sangyong Jon et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Encapsulation for Cancer Therapy
- (2020) Xavier Montané et al. MOLECULES
- Nanomedicine-based drug delivery towards tumor biological and immunological microenvironment
- (2020) Jin Li et al. Acta Pharmaceutica Sinica B
- The progress and perspective of nanoparticle-enabled tumor metastasis treatment
- (2020) Wei Zhang et al. Acta Pharmaceutica Sinica B
- Synergistic tumor immunological strategy by combining tumor nanovaccine with gene-mediated extracellular matrix scavenger
- (2020) Yingying Hu et al. BIOMATERIALS
- A DNA nanodevice-based vaccine for cancer immunotherapy
- (2020) Shaoli Liu et al. NATURE MATERIALS
- A tumor-to-lymph procedure navigated versatile gel system for combinatorial therapy against tumor recurrence and metastasis
- (2020) Lin Qin et al. Science Advances
- Manipulation of immune‒vascular crosstalk: new strategies towards cancer treatment
- (2020) Yang Zhao et al. Acta Pharmaceutica Sinica B
- Antigens reversibly conjugated to a polymeric glyco-adjuvant induce protective humoral and cellular immunity
- (2019) D. Scott Wilson et al. NATURE MATERIALS
- Emerging Nano-/Microapproaches for Cancer Immunotherapy
- (2019) Yu Mi et al. Advanced Science
- Targeted Codelivery of an Antigen and Dual Agonists by Hybrid Nanoparticles for Enhanced Cancer Immunotherapy
- (2019) Linhua Zhang et al. NANO LETTERS
- Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets
- (2019) Luca Cassetta et al. CANCER CELL
- A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer
- (2019) Johanna Wagner et al. CELL
- Non-viral nano-immunotherapeutics targeting tumor microenvironmental immune cells
- (2019) Seok-Beom Yong et al. BIOMATERIALS
- Peptides conjugated to 2-alkoxy-8-oxo-adenine as potential synthetic vaccines triggering TLR7
- (2019) Geoffroy P.P. Gential et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Final analyses of OPTiM: a randomized phase III trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in unresectable stage III–IV melanoma
- (2019) Robert H. I. Andtbacka et al. Journal for ImmunoTherapy of Cancer
- Opposing Functions of Interferon Coordinate Adaptive and Innate Immune Responses to Cancer Immune Checkpoint Blockade
- (2019) Joseph L. Benci et al. CELL
- Immunization with mannosylated nanovaccines and inhibition of the immune-suppressing microenvironment sensitizes melanoma to immune checkpoint modulators
- (2019) João Conniot et al. Nature Nanotechnology
- Co-localized delivery of nanomedicine and nanovaccine augments the postoperative cancer immunotherapy by amplifying T-cell responses
- (2019) Xiang Liu et al. BIOMATERIALS
- Cancer Cell Membrane-Coated Adjuvant Nanoparticles with Mannose Modification for Effective Anticancer Vaccination
- (2018) Rong Yang et al. ACS Nano
- Highly enhanced cancer immunotherapy by combining nanovaccine with hyaluronidase
- (2018) Xiuwen Guan et al. BIOMATERIALS
- Design and immunological evaluation of anti-CD205-tailored PLGA-based nanoparticulate cancer vaccine
- (2018) Sheikh Tasnim Jahan et al. International Journal of Nanomedicine
- Nivolumab Plus Ipilimumab in Patients With Advanced Melanoma: Updated Survival, Response, and Safety Data in a Phase I Dose-Escalation Study
- (2018) Margaret K. Callahan et al. JOURNAL OF CLINICAL ONCOLOGY
- An indoleamine 2, 3-dioxygenase siRNA nanoparticle-coated and Trp2-displayed recombinant yeast vaccine inhibits melanoma tumor growth in mice
- (2018) Dong-qun Liu et al. JOURNAL OF CONTROLLED RELEASE
- mRNA vaccines — a new era in vaccinology
- (2018) Norbert Pardi et al. NATURE REVIEWS DRUG DISCOVERY
- Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti–PD-1 treatment
- (2018) Elisa Peranzoni et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tumor-associated macrophages promote progression and the Warburg effect via CCL18/NF-kB/VCAM-1 pathway in pancreatic ductal adenocarcinoma
- (2018) Huilin Ye et al. Cell Death & Disease
- Advances and Opportunities in Nanoparticle- and Nanomaterial-Based Vaccines against Bacterial Infections
- (2018) Leon Chien-Wei Lin et al. Advanced Healthcare Materials
- Neoantigen Vaccine Delivery for Personalized Anticancer Immunotherapy
- (2018) Yugang Guo et al. Frontiers in Immunology
- Contribution to Tumor Angiogenesis From Innate Immune Cells Within the Tumor Microenvironment: Implications for Immunotherapy
- (2018) Adriana Albini et al. Frontiers in Immunology
- Antitumor activity of CAR-T cells targeting the intracellular oncoprotein WT1 can be enhanced by vaccination
- (2018) Yasushi Akahori et al. BLOOD
- Biomaterial-assisted targeted modulation of immune cells in cancer treatment
- (2018) Hua Wang et al. NATURE MATERIALS
- Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma
- (2018) Noam Auslander et al. NATURE MEDICINE
- Cytokines in clinical cancer immunotherapy
- (2018) Pedro Berraondo et al. BRITISH JOURNAL OF CANCER
- Actively personalized vaccination trial for newly diagnosed glioblastoma
- (2018) Norbert Hilf et al. NATURE
- Cancer immunoediting and resistance to T cell-based immunotherapy
- (2018) Jake S. O’Donnell et al. Nature Reviews Clinical Oncology
- Targeting macrophages: therapeutic approaches in cancer
- (2018) Luca Cassetta et al. NATURE REVIEWS DRUG DISCOVERY
- Colorectal cancer vaccines: Tumor-associated antigens vs neoantigens
- (2018) Sandra Wagner et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Metabolism and TAM functions-it takes two to tango
- (2017) Massimiliano Mazzone et al. FEBS Journal
- Cationic liposomes promote antigen cross-presentation in dendritic cells by alkalizing the lysosomal pH and limiting the degradation of antigens
- (2017) Jie Gao et al. International Journal of Nanomedicine
- Encapsulation of two different TLR ligands into liposomes confer protective immunity and prevent tumor development
- (2017) Banu Bayyurt et al. JOURNAL OF CONTROLLED RELEASE
- Immunogenic Cell Death Amplified by Co-localized Adjuvant Delivery for Cancer Immunotherapy
- (2017) Yuchen Fan et al. NANO LETTERS
- Cancer immunotherapy
- (2017) Eric Bender NATURE
- T-cell invigoration to tumour burden ratio associated with anti-PD-1 response
- (2017) Alexander C. Huang et al. NATURE
- Chimeric antigen receptor T-cell therapy — assessment and management of toxicities
- (2017) Sattva S. Neelapu et al. Nature Reviews Clinical Oncology
- Tumour-associated macrophages as treatment targets in oncology
- (2017) Alberto Mantovani et al. Nature Reviews Clinical Oncology
- Monitoring immune-checkpoint blockade: response evaluation and biomarker development
- (2017) Mizuki Nishino et al. Nature Reviews Clinical Oncology
- Cancer immunotherapy — immune checkpoint blockade and associated endocrinopathies
- (2017) David J. Byun et al. Nature Reviews Endocrinology
- Dissolving Microneedle Arrays for Transdermal Delivery of Amphiphilic Vaccines
- (2017) Myunggi An et al. Small
- Intertwining DNA-RNA nanocapsules loaded with tumor neoantigens as synergistic nanovaccines for cancer immunotherapy
- (2017) Guizhi Zhu et al. Nature Communications
- Coinhibitory Pathways in Immunotherapy for Cancer
- (2016) Susanne H. Baumeister et al. Annual Review of Immunology
- Artificial bacterial biomimetic nanoparticles synergize pathogen-associated molecular patterns for vaccine efficacy
- (2016) Alyssa L. Siefert et al. BIOMATERIALS
- Exosome-based tumor antigens–adjuvant co-delivery utilizing genetically engineered tumor cell-derived exosomes with immunostimulatory CpG DNA
- (2016) Masaki Morishita et al. BIOMATERIALS
- Myeloid-Derived Suppressor Cells Express Bruton's Tyrosine Kinase and Can Be Depleted in Tumor-Bearing Hosts by Ibrutinib Treatment
- (2016) Andrew Stiff et al. CANCER RESEARCH
- Indoleamine 2,3-dioxygenase (IDO): Biology and Target in Cancer Immunotherapies
- (2016) Senthamil R. Selvan et al. CURRENT CANCER DRUG TARGETS
- Biomaterials for enhancing anti-cancer immunity
- (2016) Sandeep T Koshy et al. CURRENT OPINION IN BIOTECHNOLOGY
- The impact of hypoxia on tumor-associated macrophages
- (2016) Anne-Theres Henze et al. JOURNAL OF CLINICAL INVESTIGATION
- Orchestrating immune responses: How size, shape and rigidity affect the immunogenicity of particulate vaccines
- (2016) Naomi Benne et al. JOURNAL OF CONTROLLED RELEASE
- Designer vaccine nanodiscs for personalized cancer immunotherapy
- (2016) Rui Kuai et al. NATURE MATERIALS
- Erratum: The future of cancer treatment: immunomodulation, CARs and combination immunotherapy
- (2016) Danny N. Khalil et al. Nature Reviews Clinical Oncology
- Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy
- (2016) Alexander M.M. Eggermont et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
- (2016) Weiping Zou et al. Science Translational Medicine
- Targeting dendritic cells in humanized mice receiving adoptive T cells via monoclonal antibodies fused to Flu epitopes
- (2016) John P. Graham et al. VACCINE
- Near-infrared labeled, ovalbumin loaded polymeric nanoparticles based on a hydrophilic polyester as model vaccine: In vivo tracking and evaluation of antigen-specific CD8 + T cell immune response
- (2015) Sima Rahimian et al. BIOMATERIALS
- Nanovaccine loaded with poly I:C and STAT3 siRNA robustly elicits anti-tumor immune responses through modulating tumor-associated dendritic cells in vivo
- (2015) Zichao Luo et al. BIOMATERIALS
- Developments in cancer vaccines for hepatocellular carcinoma
- (2015) Luigi Buonaguro et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Synthetic Nanoparticles for Vaccines and Immunotherapy
- (2015) Darrell J. Irvine et al. CHEMICAL REVIEWS
- Cancer immunotherapy: harnessing the immune system to battle cancer
- (2015) Yiping Yang JOURNAL OF CLINICAL INVESTIGATION
- Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma
- (2015) Dirk Schadendorf et al. JOURNAL OF CLINICAL ONCOLOGY
- Immune Checkpoint Blockade in Cancer Therapy
- (2015) Michael A. Postow et al. JOURNAL OF CLINICAL ONCOLOGY
- The interaction of anticancer therapies with tumor-associated macrophages
- (2015) Alberto Mantovani et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Cancer immunotherapy meets biomaterials
- (2015) Jeffrey S Weber et al. NATURE BIOTECHNOLOGY
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma
- (2015) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Therapeutic antitumor immunity by checkpoint blockade is enhanced by ibrutinib, an inhibitor of both BTK and ITK
- (2015) Idit Sagiv-Barfi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The future of immune checkpoint therapy
- (2015) P. Sharma et al. SCIENCE
- Cancer vaccines in the new era of cancer immunotherapy
- (2015) Keith L. Knutson et al. VACCINE
- Porous Silicon Microparticle Potentiates Anti-Tumor Immunity by Enhancing Cross-Presentation and Inducing Type I Interferon Response
- (2015) Xiaojun Xia et al. Cell Reports
- Dendritic cell targeted vaccines: Recent progresses and challenges
- (2015) Pengfei Chen et al. Human Vaccines & Immunotherapeutics
- Overcoming transport barriers for interstitial-, lymphatic-, and lymph node-targeted drug delivery
- (2015) Susan N Thomas et al. Current Opinion in Chemical Engineering
- The origin and function of tumor-associated macrophages
- (2014) Yang Liu et al. Cellular & Molecular Immunology
- Targeting nanoparticles to CD40, DEC-205 or CD11c molecules on dendritic cells for efficient CD8+ T cell response: A comparative study
- (2014) Luis J. Cruz et al. JOURNAL OF CONTROLLED RELEASE
- IL-2: The First Effective Immunotherapy for Human Cancer
- (2014) S. A. Rosenberg JOURNAL OF IMMUNOLOGY
- Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery
- (2014) Ronnie H. Fang et al. NANO LETTERS
- Structure-based programming of lymph-node targeting in molecular vaccines
- (2014) Haipeng Liu et al. NATURE
- The cellular and molecular origin of tumor-associated macrophages
- (2014) R. A. Franklin et al. SCIENCE
- Clinical evaluation of compounds targeting PD-1/PD-L1 pathway for cancer immunotherapy
- (2014) Jing Lu et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
- (2013) Nicolas Bertrand et al. ADVANCED DRUG DELIVERY REVIEWS
- The Dendritic Cell Lineage: Ontogeny and Function of Dendritic Cells and Their Subsets in the Steady State and the Inflamed Setting
- (2013) Miriam Merad et al. Annual Review of Immunology
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- Self-reinforced endocytoses of smart polypeptide nanogels for “on-demand” drug delivery
- (2013) Jianxun Ding et al. JOURNAL OF CONTROLLED RELEASE
- Cancer Immunotherapy
- (2013) M. McNutt SCIENCE
- Tumor Endothelial Cells
- (2013) A. C. Dudley Cold Spring Harbor Perspectives in Medicine
- Nanoparticle-Based Vaccine Delivery for Cancer Immunotherapy
- (2013) Yeong-Min Park et al. Immune Network
- Differential requirements of CD4+T-cell signals for effector cytotoxic T-lymphocyte (CTL) priming and functional memory CTL development at higher CD8+T-cell precursor frequency
- (2012) Channakeshava S. Umeshappa et al. IMMUNOLOGY
- Cationic liposomes as vaccine adjuvants
- (2011) Dennis Christensen et al. Expert Review of Vaccines
- Regulators of T-cell memory generation: TCR signals versus CD4+ help?
- (2011) Channakeshava Sokke Umeshappa et al. IMMUNOLOGY AND CELL BIOLOGY
- Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem/initiating cells
- (2011) M. Jinushi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Toll-like receptors: key players in antiviral immunity
- (2011) Nicholas Arpaia et al. Current Opinion in Virology
- Designing Vaccines Based on Biology of Human Dendritic Cell Subsets
- (2010) Karolina Palucka et al. IMMUNITY
- Mechanism of T Cell Tolerance Induced by Myeloid-Derived Suppressor Cells
- (2010) S. Nagaraj et al. JOURNAL OF IMMUNOLOGY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Regulation of Adaptive Immunity by the Innate Immune System
- (2010) A. Iwasaki et al. SCIENCE
- Local and Distant Immunity Induced by Intralesional Vaccination with an Oncolytic Herpes Virus Encoding GM-CSF in Patients with Stage IIIc and IV Melanoma
- (2009) Howard L. Kaufman et al. ANNALS OF SURGICAL ONCOLOGY
- Regulation of the IL-23 and IL-12 Balance by Stat3 Signaling in the Tumor Microenvironment
- (2009) Marcin Kortylewski et al. CANCER CELL
- Tumor-Educated CD11b high Ia low Regulatory Dendritic Cells Suppress T Cell Response through Arginase I
- (2009) Qiuyan Liu et al. JOURNAL OF IMMUNOLOGY
- Tumor-Induced Suppressor of Cytokine Signaling 3 Inhibits Toll-like Receptor 3 Signaling in Dendritic Cells via Binding to Tyrosine Kinase 2
- (2008) B. Zeng et al. CANCER RESEARCH
- Mannose-targeted systems for the delivery of therapeutics
- (2008) Juan M Irache et al. Expert Opinion on Drug Delivery
- Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans
- (2008) Troy D Querec et al. NATURE IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now